Farmak

1925 — Lomonosov Kyiv Chemical and Pharmaceutical Plant was put into operation.[3]

1950s — launch of manufacturing of radiopaque contrast agents. Development and release of Corvalolum; synthesis of new medicinal products.[4]

1960s — manufacturing of 27 medicinal products.[5]

1970s — export of products to more than 20 countries of the world, including Germany, France, Italy, Egypt, Greece, Angola.[5]

1990s — privatization of Lomonosov Kyiv Chemical and Pharmaceutical Plant and reorganization of the enterprise into JSC Farmak.[6]

2000s — signing a long-term partnership agreement with the American corporation Eli Lilly as a leader in insulin development and manufacturing. The company launched the manufacturing of genetically engineered human insulins using Eli Lilly's licensed technology.[7]

2010s — 2021s — becoming the Ukrainian pharmaceutical market leader based on the sales of medicinal products in monetary terms according to Proxima Research International.[8]

After the outbreak of the Russo-Ukrainian War, Farmak stopped registering and supplying medicinal products to the Russian Federation.[9]

In 2015, Farmak launched a new API Production Division in Shostka, Sumy Region.[10]

In 2022, Farmak closed its representative office in the Republic of Belarus, which supports the Russian invasion of Ukraine.[11]

Farmak operates a pharmaceutical plant in Kyiv and API Production Division in Shostka, Sumy Region. The company also owns a laboratory and technological R&D complex for testing new and improving existing technologies of finished medicinal products.[12]

The manufacturing facilities, laboratory and technological complex of the company are certified according to international standards and meet the requirements of European GMP standards.[13]

Farmak reinvests approximately 90% of its profits in development. Annual investments in R&D are approximately US$15 million. Investments in business development in Ukraine amounted to US$400 million over the past 20 years (2002-2022).[14]

In 2011, the Farmak Charitable Foundation was founded, succeeded by the Zhebrivski Family Charitable Foundation. Main areas of activity: providing support to the army, health care, education, restoring cultural monuments, preserving historical and cultural heritage, providing social assistance and protection to the population, overcoming COVID-19 consequences.[15]

Since 2017, JSC Farmak has held the Run for Your Health race in Shostka. The event is held on September 3 every year on the occasion of Shostka Town Day with the support of the local authorities.[16]

In 2018, JSC Farmak, in cooperation with the NGO Ukrainian Ecological Club “Green Wave”, launched Eco School informational and educational project.[17] In 2019, the Company became the first Ukrainian pharmaceutical company to join the UN Global Compact.[18]

• 2019 — TOP 100. Rating of the Largest — the first place among pharmaceutical companies in terms of the amount of taxes paid for 2018.[19]
• 2021 — Top 50 best companies of 2021.[20]
• 2021 — Top 25 Ukrainian exporting companies.[2]
• 2021 — the leader of the rating of 50 most successful Ukrainian brands according to the Focus.[21]
• 2022 — Top 50 Employers 2022.[22]